Wider procurement of G6PD tests and primaquine is planned for 2016 as the national strategy expands to introduce primaquine more widely to treat P. falciparum and radically cure P. vivax infections in patients without G6PD deficiency [1, 10]. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.